Influence of polypharmacy on patients with heart failure with preserved ejection fraction: a retrospective analysis on adverse outcomes in the TOPCAT trial
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Influence of polypharmacy on patients with heart failure with preserved ejection fraction: a retrospective analysis on adverse outcomes in the TOPCAT trial
Authors
Keywords
-
Journal
BRITISH JOURNAL OF GENERAL PRACTICE
Volume 71, Issue 702, Pages e62-e70
Publisher
Royal College of General Practitioners
Online
2020-12-01
DOI
10.3399/bjgp21x714245
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease
- (2019) Iris E. Beldhuis et al. JACC-Heart Failure
- Heart Failure With Preserved Ejection Fraction and Diabetes
- (2019) Kelly McHugh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Prevalence and determinants of Hyperpolypharmacy in adults with heart failure: an observational study from the National Health and Nutrition Examination Survey (NHANES)
- (2019) Peter J. Kennel et al. BMC Cardiovascular Disorders
- Polypharmacy and taste disorders in heart failure patients
- (2019) Yoshiharu Kinugasa et al. European Journal of Preventive Cardiology
- Adherence to Disease-Modifying Therapy in Patients Hospitalized for HF: Findings from a Community-Based Study
- (2019) Marta Spreafico et al. American Journal of Cardiovascular Drugs
- Association of Total Medication Burden With Intensive and Standard Blood Pressure Control and Clinical Outcomes: A Secondary Analysis of SPRINT
- (2019) Catherine G. Derington et al. HYPERTENSION
- The role of the clinical pharmacist in the prevention of potential drug interactions in geriatric heart failure patients
- (2019) Kaloyan D. Georgiev et al. International Journal of Clinical Pharmacy
- Prescribing Patterns of Heart Failure-Exacerbating Medications Following a Heart Failure Hospitalization
- (2019) Parag Goyal et al. JACC-Heart Failure
- A Review of the Role of the Pharmacist in Heart Failure Transition of Care
- (2018) Sarah L. Anderson et al. ADVANCES IN THERAPY
- Low diastolic blood pressure and adverse outcomes in heart failure with preserved ejection fraction
- (2018) Tetsuro Tsujimoto et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Diastolic Blood Pressure and Adverse Outcomes in the TOPCAT (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist) Trial
- (2018) Pratik B. Sandesara et al. Journal of the American Heart Association
- Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction
- (2018) Maja Cikes et al. JACC-Heart Failure
- Drug therapy problems and contributing factors in the management of heart failure patients in Jimma University Specialized Hospital, Southwest Ethiopia
- (2018) Yirga Legesse Niriayo et al. PLoS One
- Association Between Functional Impairment and Medication Burden in Adults with Heart Failure
- (2018) Parag Goyal et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Epidemiology of heart failure with preserved ejection fraction
- (2017) Shannon M. Dunlay et al. Nature Reviews Cardiology
- What is polypharmacy? A systematic review of definitions
- (2017) Nashwa Masnoon et al. BMC Geriatrics
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN JOURNAL OF HEART FAILURE
- Polypharmacy in heart failure — Is reducing medication safe?
- (2016) Ingrid Hopper et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Medication Therapy Management Interventions in Outpatient Settings
- (2015) Meera Viswanathan et al. JAMA Internal Medicine
- Temporal Trends in Polypharmacy and Hyperpolypharmacy in Older New Zealanders over a 9-Year Period: 2005-2013
- (2014) Prasad S. Nishtala et al. GERONTOLOGY
- Can Medications be Safely Withdrawn in Patients With Stable Chronic Heart Failure? Systematic Review and Meta-analysis
- (2014) Ingrid Hopper et al. JOURNAL OF CARDIAC FAILURE
- Spironolactone for Heart Failure with Preserved Ejection Fraction
- (2014) Bertram Pitt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comorbidities and Polypharmacy
- (2014) Thomas G. von Lueder et al. Heart Failure Clinics
- Impact of Noncardiac Comorbidities on Morbidity and Mortality in a Predominantly Male Population With Heart Failure and Preserved Versus Reduced Ejection Fraction
- (2012) Sameer Ather et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure
- (2011) Catherine Y. Wong et al. AMERICAN JOURNAL OF MEDICINE
- Medication Adherence Among Community-Dwelling Patients With Heart Failure
- (2011) Shannon M. Dunlay et al. MAYO CLINIC PROCEEDINGS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now